Experimental thymology has come of age

T-cell antigen receptors: fact and artefact.

Immunology today·2014

Identifying quantitative trait loci for resistance to Sclerotinia head rot in two USDA sunflower germplasms.

Phytopathology·2008

Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS.

Journal of bacteriology·2006

Immune self-tolerance mechanisms.

Transplantation·2002

Construction of mini-Tn5cyaA' and its utilization for the identification of genes encoding surface-exposed and secreted proteins in Bordetella bronchiseptica.

FEMS microbiology letters·2001

Mechanisms of Bordetella pathogenesis.

Frontiers in bioscience : a journal and virtual library·2001

Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.

Thymus·1997

Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.

Thymus·1997

Modulation of cytokine gene expression by thymic lympho-stromal cell to cell interaction: effect of retinoic acid.

Thymus·1997

Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.

Thymus·1997

Presence of nerve growth factor in the thymus of prenatal, postnatal and pregnant rats.

Thymus·1997

Loss of T-cell cytotoxic responses in the course of HIV-1 infection.

Thymus·1997

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Related Experiment Videos

Experimental thymology has come of age

Related Concept Videos

T-cell antigen receptors: fact and artefact.

Identifying quantitative trait loci for resistance to Sclerotinia head rot in two USDA sunflower germplasms.

Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS.

Immune self-tolerance mechanisms.

Construction of mini-Tn5cyaA' and its utilization for the identification of genes encoding surface-exposed and secreted proteins in Bordetella bronchiseptica.

Mechanisms of Bordetella pathogenesis.

Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization.

Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.

Modulation of cytokine gene expression by thymic lympho-stromal cell to cell interaction: effect of retinoic acid.

Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.

Presence of nerve growth factor in the thymus of prenatal, postnatal and pregnant rats.

Loss of T-cell cytotoxic responses in the course of HIV-1 infection.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Related Experiment Videos

Experimental thymology has come of age

Related Concept Videos

Related Articles